Barbara L Weber

发表

Genetic variants of uncertain significance: flies in the ointment.

B. Weber, S. Domchek, Susan Domchek, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments.

Christian J Stoeckert, Joel Greshock, Tara L. Naylor, 2006, Genome research.

Structure-Based Assessment of Missense Mutations in Human BRCA1

Nebojsa Mirkovic, Andrej Sali, Marc A Marti-Renom, 2004, Cancer Research.

Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines

Joel Greshock, Richard Wooster, R. Wooster, 2008, Molecular Cancer Therapeutics.

Integrative Genomic Analysis of Phosphatidylinositol 3′-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer

Joel Greshock, George Coukos, N. Yang, 2007, Clinical Cancer Research.

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.

Joel Greshock, Stefano Volinia, George Coukos, 2008, Cancer research.

A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.

Joel Greshock, George Coukos, Xiaowen Hu, 2012, Cancer research.

Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.

Zhimin Huo, Maryellen L Giger, Charles E Metz, 2002, Radiology.

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

Leif E. Peterson, Giovanni Parmigiani, Christopher I Amos, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

Joel Greshock, Tara L. Naylor, Yan Wang, 2005, Breast Cancer Research.

High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma

Adam A. Margolin, Joel Greshock, Cynthia Winter, 2005, Genes, chromosomes & cancer.

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Susan L Neuhausen, Olufunmilayo I Olopade, Judy E Garber, 2002, The New England journal of medicine.

Integrated analysis of breast cancer cell lines reveals unique signaling pathways

Zhi Hu, Merrill Knapp, Laura M. Heiser, 2009, Genome Biology.

Characterization of adjacent breast tumors using oligonucleotide microarrays

Michael N Liebman, L. Chodosh, B. Weber, 2001, Breast Cancer Research.

Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.

Michael D Feldman, Olufunmilayo I Olopade, O. Olopade, 2002, Cancer research.

BRAF and RAS mutations in human lung cancer and melanoma.

Richard Wooster, Helen Davies, Michael R Stratton, 2002, Cancer research.

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Susan L Neuhausen, Olufunmilayo I Olopade, Judy E Garber, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.

Nazneen Rahman, Carel Meijers, Sheila Seal, 2003, American journal of human genetics.

Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

T. Rebbeck, B. Weber, K. Nathanson, 2002, Journal of the National Cancer Institute.

1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis.

Shaying Zhao, Adam A. Margolin, Joel Greshock, 2003, Genome research.

Accuracy of cancer family histories: comparison of two breast cancer syndromes.

Neil Klar, Judy E Garber, A. Patenaude, 2004, Genetic testing.

Cancer genomics

B. Weber, Barbara L Weber, Barbara L. Weber, 2002 .

Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization.

Joel Greshock, George Coukos, Katherine Nathanson, 2007, Cancer research.

BRAF as a potential therapeutic target in melanoma and other malignancies.

Meenhard Herlyn, B. Weber, D. Tuveson, 2003, Cancer cell.

BRCA1 physically associates with p53 and stimulates its transcriptional activity

Hui Tian, Wafik S El-Deiry, Hongbing Zhang, 1998, Oncogene.